TrialThe oncologist2020
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Carl M Gay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialThe oncologist2020
Carl M Gay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.